Infusions, Parenteral

"Infusions, Parenteral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.

Descriptor ID	D007263
MeSH Number(s)	E02.319.267.510
Concept/Terms	Infusions, Parenteral Infusions, Parenteral Parenteral Infusions Infusion, Parenteral Parenteral Infusion Intra-Abdominal Infusions Intra-Abdominal Infusions Infusion, Intra-Abdominal Infusions, Intra-Abdominal Intra Abdominal Infusions Intra-Abdominal Infusion Peritoneal Infusions Infusion, Peritoneal Infusions, Peritoneal Peritoneal Infusion Intraperitoneal Infusions Infusion, Intraperitoneal Infusions, Intraperitoneal Intraperitoneal Infusion

Below are MeSH descriptors whose meaning is more general than "Infusions, Parenteral".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Infusions, Parenteral [E02.319.267.510]

Below are MeSH descriptors whose meaning is related to "Infusions, Parenteral".

Below are MeSH descriptors whose meaning is more specific than "Infusions, Parenteral".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Infusions, Parenteral" by people in this website by year, and whether "Infusions, Parenteral" was a major or minor topic of these publications.

Bar chart showing 18 publications over 12 distinct years, with a maximum of 3 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	2	2
2006	0	1	1
2007	0	3	3
2009	0	1	1
2010	0	1	1
2012	0	1	1
2013	0	1	1
2014	1	1	2
2016	0	2	2
2017	0	2	2
2021	0	1	1

Below are the most recent publications written about "Infusions, Parenteral" by people in Profiles.

Denlinger LC, Phillips BR, Sorkness RL, Bleecker ER, Castro M, DeBoer MD, Fitzpatrick AM, Hastie AT, Gaffin JM, Moore WC, Peters MC, Peters SP, Phipatanakul W, Cardet JC, Erzurum SC, Fahy JV, Fajt ML, Gaston B, Levy BD, Meyers DA, Ross K, Teague WG, Wenzel SE, Woodruff PG, Zein J, Jarjour NN, Mauger DT, Israel E. Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate-to-Severe Asthma. Am J Respir Crit Care Med. 2021 04 01; 203(7):841-852.

View in: PubMed
Malik F, Ali N, Jafri SIM, Ghani A, Hamid M, Boigon M, Fidler C. Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report. J Med Case Rep. 2017 Apr 24; 11(1):119.

View in: PubMed
Jandial DA, Brady WE, Howell SB, Lankes HA, Schilder RJ, Beumer JH, Christner SM, Strychor S, Powell MA, Hagemann AR, Moore KN, Walker JL, DiSilvestro PA, Duska LR, Fracasso PM, Dizon DS. A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 May; 145(2):236-242.

View in: PubMed
Boisen MM, Lesnock JL, Richard SD, Beriwal S, Kelley JL, Zorn KK, Edwards RP. Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2016 May; 26(4):626-31.

View in: PubMed
Choudhry DK, Brenn BR, Sacks K, Reichard K. Continuous chest wall ropivacaine infusion for analgesia in children undergoing Nuss procedure: a comparison with thoracic epidural. Paediatr Anaesth. 2016 Jun; 26(6):582-9.

View in: PubMed
Whiteman LN, Lanzkron S, Stewart RW, Haywood C, Strouse JJ, Feldman L. Quality improvement process in a sickle cell infusion center. Am J Med. 2015 May; 128(5):541-4.

View in: PubMed
Coccolini F, Campanati L, Catena F, Ceni V, Ceresoli M, Jimenez Cruz J, Lotti M, Magnone S, Napoli J, Rossetti D, De Iaco P, Frigerio L, Pinna A, Runnebaum I, Ansaloni L. Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. J Gynecol Oncol. 2015 Jan; 26(1):54-61.

View in: PubMed
Harrison LE, Tiesi G, Razavi R, Wang CC. A phase I trial of thermal sensitization using induced oxidative stress in the context of HIPEC. Ann Surg Oncol. 2013 Jun; 20(6):1843-50.

View in: PubMed
Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes. Int J Gynecol Cancer. 2012 Feb; 22(2):232-7.

View in: PubMed
Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, Lentz SS, Levine EA, Loggie BW, Metzinger DS, Miller B, Parker L, Spellman JE, Sugarbaker PH, Edwards RP, Rai SN. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010 Jan; 20(1):61-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement